FDA DEVICE EVALUATION PRODUCTIVITY FIGURES WILL BE PUBLISHED MONTHLY
This article was originally published in The Gray Sheet
Executive Summary
FDA DEVICE EVALUATION PRODUCTIVITY FIGURES WILL BE PUBLISHED MONTHLY if the proposed medical device user fee bill (HR 4782) is enacted, Center for Devices and Radiological Health Director Brace Burlington promised July 19 at a Health Industry Manufacturers Association meeting in Arlington, Virginia. As a demonstration of agency accountability under a device user fee program, Burlington said, FDA would "make public [its] month-to-month statistical analysis of what the review program is doing."
You may also be interested in...
‘Parity To The Originator Is Not Enough’ – Cardinal Health Talks US Biosimilars
Following what Cardinal Health described as “a year of monumental developments in biosimilars,” the firm’s director of biosimilars, Dracey Poore, spoke to Generics Bulletin for an exclusive Q&A.
Fresenius And Formycon Strike Stelara Settlement For Europe And Canada
Partners Fresenius Kabi and Formycon have laid the groundwork to launch their biosimilar ustekinumab rival to Stelara in Europe and Canada through a settlement agreement with originator J&J.
Sumitomo To Reprioritize Pipeline After Ulotaront’s Phase III Fail
Sumitomo Pharma is to focus more on late-stage candidates in oncology and cell/gene therapy while passing on full global rights for ulotaront and SEP-380135 to Otsuka.